VioQuest Pharmaceuticals, Inc.
OTC: VOQP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mark D. Dacko
- Employees
- 3
- Headquarters
- Basking Ridge, United States
- IPO year
- 1994
- Market cap
- $14.7K
- Website
- http://www.vioquestpharm.com
Loading VOQP…
Loading profile data…Frequently asked questions about VOQP
What does VioQuest Pharmaceuticals, Inc. (VOQP) do?
VioQuest Pharmaceuticals, Inc. is a biopharmaceutical entity that concentrates on obtaining, developing, and marketing drug therapies in clinical stages, specifically targeting oncology and infectious diseases. Its primary product, Xyfid, is currently being advanced for both the management and prevention of hand-foot syndrome. The company's pipe...
Where does VOQP trade?
VioQuest Pharmaceuticals, Inc. (VOQP) trades on the Other OTC.
What sector is VOQP in?
VioQuest Pharmaceuticals, Inc. (VOQP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of VioQuest Pharmaceuticals, Inc.?
Mark D. Dacko is the chief executive officer of VioQuest Pharmaceuticals, Inc. (VOQP).
Where is VioQuest Pharmaceuticals, Inc. headquartered?
VioQuest Pharmaceuticals, Inc. is headquartered in United States.
Does VOQP pay a dividend?
VioQuest Pharmaceuticals, Inc. (VOQP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VOQP go public?
VioQuest Pharmaceuticals, Inc. (VOQP) completed its initial public offering in 1994.